ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Dichloromethane → ethyl 1-(2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl)-4-(2-(7-methoxy-4-methyl-2-oxoquinolin-1(2H)-yl)ethyl)piperazine-2-carboxylate

HRID 2193178
印刷

反応式

HRID 2193178 の反応式
ClCCl.[O:4]1[C:9]2[CH:10]=[CH:11][C:12]([CH2:14][CH2:15][N:16]3[CH2:21][CH2:20][NH:19][CH2:18][CH:17]3[C:22]([O:24][CH2:25][CH3:26])=[O:23])=[CH:13][C:8]=2[O:7][CH2:6][CH2:5]1.[CH3:27][O:28][C:29]1[CH:38]=[C:37]2[C:32]([C:33]([CH3:43])=[CH:34][C:35](=[O:42])[N:36]2[CH2:39][CH:40]=O)=[CH:31][CH:30]=1.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>O.C(Cl)(Cl)Cl.C(O)(=O)C>[O:4]1[C:9]2[CH:10]=[CH:11][C:12]([CH2:14][CH2:15][N:16]3[CH2:21][CH2:20][N:19]([CH2:40][CH2:39][N:36]4[C:37]5[C:32](=[CH:31][CH:30]=[C:29]([O:28][CH3:27])[CH:38]=5)[C:33]([CH3:43])=[CH:34][C:35]4=[O:42])[CH2:18][CH:17]3[C:22]([O:24][CH2:25][CH3:26])=[O:23])=[CH:13][C:8]=2[O:7][CH2:6][CH2:5]1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 6344DichloromethaneHCID 5049666Sodium triacetoxyborohydrideHCID 59397837(7-methoxy-4-methyl-2-oxoquinolin-1(2H)-yl)acetaldehydeHCID 59398324Ethyl 1-(2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl)piperazine-2-carboxylate

生成物 1

HCID 59398294ethyl 1-(2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl)-4-(2-(7-methoxy-4-methyl-2-oxoquinolin-1(2H)-yl)ethyl)piperazine-2-carboxylate
収率 64.8%

試薬・触媒・溶媒 3

HCID 176Acetic Acid溶媒HCID 962Water溶媒HCID 6212Chloroform溶媒

実験手順

To 2.5 mL of dichloromethane solution containing 0.14 g of ethyl 1-(2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl)piperazine-2-carboxylate and 0.10 g of (7-methoxy-4-methyl-2-oxoquinolin-1(2H)-yl)acetaldehyde, 25 μL of acetic acid were added and stirred at room temperature for 50 min. Then, 0.14 g of sodium triacetoxyborohydride was added, and stirred at room temperature for 1 hour. To the reaction mixture, chloroform and water were added, the organic layer was separated, and the aqueous layer was extracted with chloroform. The organic layer and extracts were combined, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue thus obtained was purified by silica gel column chromatography [eluent; chloroform:acetone=50 1], to give 0.15 g of ethyl 1-(2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl)-4-(2-(7-methoxy-4-methyl-2-oxoquinolin-1(2H)-yl)ethyl)piperazine-2-carboxylate as a colorless foam.

後処理

  1. additionwere added
  2. stirringstirred at room temperature for 1 hour
  3. customthe organic layer was separated
  4. extractionthe aqueous layer was extracted with chloroform
  5. dry with materialdried over anhydrous magnesium sulfate
  6. customthe solvent was removed under reduced pressure
  7. customThe residue thus obtained
  8. customwas purified by silica gel column chromatography [eluent; chloroform:acetone=50 1]

出典と根拠

ORDレコード
ord-64a8976538584820b2d1043a5befe114
出典データセット
uspto-grants-2012_12
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08329694B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート